Items tagged with HIV coinfection

UGA researchers discover potential treatment for drug-resistant tuberculosis (post)

Athens, Ga. - Researchers at the University of Georgia have developed a new small molecule drug that may serve as a treatment against multidrug-resistant tuberculosis, a form of the disease that cannot be cured with conventional therapies. They describe their findings in a paper published recently in Bioorganic and Medicinal Chemistry Letters.

Liver disease, TB prevalent in South African patients with HIV (post)

Liver disease and tuberculosis were common in a cohort of adult South African patients with HIV, according to data from a retrospective study. 

Starting HIV treatment at CD4 count above 500 reduces the risk of serious illness and death by 44%, African Temprano trial shows (post)

Starting HIV treatment at a CD4 cell count above 500 reduced the risk of serious illness including tuberculosis (TB), and death, by 44% when compared to starting treatment according to World Health Organization (WHO) guidelines, results from the seven-year Temprano study show. The findings were presented on Wednesday (February 25) at the Conference on Retroviruses and Opportunistic Infections (CROI 2015) in Seattle, USA.

Patients with HIV play key role in TB transmission (post)

SEATTLE — In contrast to previous hypotheses, HIV-positive patients with pulmonary tuberculosis appear to have an important function in the onward transmission of Mycobacterium tuberculosis, according to findings presented at CROI 2015.

TB/HIV Research Frontiers Meeting in conjunction with the 22nd Conference on Retroviruses and Opportunistic Infections (CROI 2015) (post)

The 9th meeting on HIV/TB research in conjunction with CROI 2015 was organised by the World Health Organisation (WHO) in Seattle, USA on February 23, 2015. The meeting was convened by Haileyesus Getahun and Meg Doherty of WHO and chaired by Richard Chaisson of John Hopkins University and Constance Benson of University of California, San Diego. The meeting was opened with remarks from Eric Goosby, the UN Special Envoy on Tuberculosis, who briefly shared his plans to support the advancement of TB research which is now included as one of the three pillars of the WHO’s new End TB Strategy.

UNAIDS calls for integration of services to end the dual epidemics of tuberculosis and HIV (post)

GENEVA, 24 March 2015—On World Tuberculosis (TB) Day, UNAIDS is calling for the scale-up of integrated HIV and TB services, particularly in the countries and regions most affected by the dual epidemics. Worldwide, 9 million people developed TB in 2013 and 1.5 million people still die of the disease every year. TB entrenches poverty in many countries, with annual income falling by an average of around 50% among affected families.   

Latent TB: a time bomb among people living with HIV in Kenya (post)

World TB Day (24 March) highlights the need to reach, treat and cure everyone who has the disease. So why are people living with HIV in Kenya, who could also have latent tuberculosis, not offered effective diagnostic tests which mean they can receive early treatment?

Page 12 of 52 · Total posts: 0

←First 11 12 13 Last→